相关实验视频

Updated: Sep 16, 2025

Development of Recombinant Proteins to Treat Chronic Pain

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

人性化scFv分子特定于P2X4R的细胞外皮图,作为慢性疼痛管理治疗方法

Adinarayana Kunamneni¹, Karin N Westlund²

¹Department of Internal Medicine, Mayo Clinic, Jacksonville, FL 32224, USA.

|July 11, 2025

概括

一种针对P2X4受体的新型非阿片类生物药物有效地逆转慢性神经损伤疼痛. 这种单链片变量 (scFv) 提供了超过100天的持久缓解,提供了一个新的治疗途径.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

慢性疼痛影响了许多人,目前的治疗方法只能提供有限的缓解.
神经损伤触发ATP释放,激活P2X4受体 (P2X4R) 并引起慢性疼痛.
现有的治疗方法往往无法提供足够的或持久的疼痛管理.

研究的目的:

开发和描述一个人性化的单链片段变量 (hscFv) 生物向P2X4R.
评估这种非阿片类生物药物在逆转与疼痛相关的行为中的有效性.
建立一种用于慢性神经损伤疼痛的新型治疗方法.

主要方法:

通过CDR移植对抗P2X4R抗体进行人性化,产生9种hscFv变异.
通过ELISA和Octet测量来确定结合亲和力和动力学 (KD=2.5 × 10-9 M对于候选物HC3-LC3).
在体内验证使用节省的神经损伤 (SNI) 模型来评估疼痛逆转.

主要成果:

人性化的scFv变体显示了对P2X4R的纳米分子结合亲和力.
单剂量 hscFv (HC3-LC3) 在两周内逆转了神经损伤引起的疼痛行为.
观察到持续的疼痛减轻 (>100天) 和焦虑/抑郁措施的逆转.

结论:

开发了有效的非阿片类药物 hscFv 生物药物,针对慢性疼痛的 P2X4R.
在临床前模型中证明了神经损伤疼痛和相关行为的持久逆转.
介绍了一种有希望的新策略,用于在没有阿片类药物的情况下管理慢性疼痛.

关键词:

亚洛迪尼亚 (Allodynia) 是一种全气体的现象.动物模型动物模型慢性疼痛是一种慢性疼痛.细胞因子细胞因子神经损伤的神经损伤神经病变性疼痛是一种神经性疼痛.其他非阿片类药物核糖体显示器可以显示核糖体.坐骨神经的坐骨神经神经.单链片段变量 (scFv) 是一个单链片段变量.三角神经是三角神经的一部分.

更多相关视频

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

Screening Peptides that Activate MRGPRX2 using Engineered HEK Cells

Screening Peptides that Activate MRGPRX2 using Engineered HEK Cells

Published on: November 6, 2021

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Opioid Receptors: Overview

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...